These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 12576843)

  • 21. The associations among GNB3 C825T polymorphism, erectile dysfunction, and related risk factors.
    Lee YC; Lin HH; Wang CJ; Liu CC; Wu WJ; Huang CH; Chang LL
    J Sex Med; 2008 Sep; 5(9):2061-8. PubMed ID: 18783529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5).
    Salvi F; Sarzani R; Giorgi R; Donatelli G; Pietrucci F; Micheli A; Baldoni M; Minardi D; Dessì-Fulgheri P; Polito M; Muzzonigro G; Rappelli A
    Int J Impot Res; 2004 Oct; 16(5):412-7. PubMed ID: 15175637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating erectile dysfunction: oral sildenafil versus intracavernosal injection of papaverine.
    Viswaroop B; B A; Gopalakrishnan G
    Natl Med J India; 2005; 18(6):299-301. PubMed ID: 16483029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice.
    Rajpurkar A; Dhabuwala CB
    J Urol; 2003 Jul; 170(1):159-63. PubMed ID: 12796670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial.
    Webster LJ; Michelakis ED; Davis T; Archer SL
    Arch Intern Med; 2004 Mar; 164(5):514-20. PubMed ID: 15006828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
    Carson CC; Hatzichristou DG; Carrier S; Lording D; Lyngdorf P; Aliotta P; Auerbach S; Murdock M; Wilkins HJ; McBride TA; Colopy MW;
    BJU Int; 2004 Dec; 94(9):1301-9. PubMed ID: 15610110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction.
    Park K; Ku JH; Kim SW; Paick JS
    BJU Int; 2005 Feb; 95(3):366-70. PubMed ID: 15679795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
    Buvat J; Hatzichristou D; Maggi M; Farmer I; Martínez-Jabaloyas JM; Miller PJ; Schnetzler G
    BJU Int; 2008 Dec; 102(11):1645-50. PubMed ID: 18710446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.
    Shabsigh R; Kaufman JM; Steidle C; Padma-Nathan H
    J Urol; 2004 Aug; 172(2):658-63. PubMed ID: 15247755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
    Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
    BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association of G-protein subunit gene C825T polymorphism with left ventricular hypertrophy in essential hypertension.
    Shlyakhto EV; Shwartz EI; Nefedova YB; Zukova AV; Vinnic TA; Konrady AO
    Med Sci Monit; 2002 May; 8(5):CR337-40. PubMed ID: 12011775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction.
    Montorsi F; Althof SE
    Urology; 2004 Apr; 63(4):762-7. PubMed ID: 15072897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825T allele of the G protein beta3 subunit gene (GNB3).
    Mitchell A; Bührmann S; Seifert A; Nürnberger J; Wenzel RR; Siffert W; Philipp T; Schäfers RF
    Clin Pharmacol Ther; 2003 Nov; 74(5):499-504. PubMed ID: 14586390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study.
    Perimenis P; Markou S; Gyftopoulos K; Giannitsas K; Athanasopoulos A; Liatsikos E; Barbalias G
    Andrologia; 2004 Jun; 36(3):106-10. PubMed ID: 15206909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity.
    McVary KT; Siegel RL; Carlsson M
    Urology; 2008 Sep; 72(3):575-9. PubMed ID: 18597830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive effect of counseling and dose adjustment in patients with erectile dysfunction who failed treatment with sildenafil.
    Gruenwald I; Shenfeld O; Chen J; Raviv G; Richter S; Cohen A; Vardi Y
    Eur Urol; 2006 Jul; 50(1):134-40. PubMed ID: 16527391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction.
    King R; Juenemann KP; Levinson IP; Stecher VJ; Creanga DL
    Int J Impot Res; 2007; 19(4):398-406. PubMed ID: 17361232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G protein beta3 subunit gene polymorphism in Turkish hypertensives.
    Alioğlu E; Ercan E; Tengiz I; Yildiz A; Onsel Türk U; Saygi S; Cam FS; Berdeli A
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):331-5. PubMed ID: 18849222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
    Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.